NovaCardia novacardia.com


Public lists: Pharma Startups (6570)

NovaCardia (San Diego, CA) is a pharmaceutical company focused on the development and commercialization of compounds for the treatment of cardiovascular diseases.

NovaCardia (San Diego, CA) is a pharmaceutical company focused on the development and commercialization of compounds for the treatment of cardiovascular diseases.

Company (Acquired)

Phone: 858-509-0455

Fax:

12750 High Bluff Drive
Suite 300
San Diego, 92130
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NovaCardia $48M Jul 26, 2007
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NovaCardia Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Kanisa Pharmaceuticals

San Diego, California, United States
Alive / ActiveKanisa Pharmaceuticals is a pharmaceutical company focused on the acquisition, development and commercialization of therapeutics in the field of oncology.Login to see details

Santarus

San Diego, California, United States
AcquiredSantarus is a specialty pharmaceutical company focused on acquiring, developing and commercializing products for the prevention and treatment of gastrointestinal diseases and disorders. The company's primary business strategy is to develop and market proprietary products with new formulations, enhanced delivery systems or expanded indications that are based on currently marketed products or compounds that have clinically demonstrated safety and efficacy.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method of improved diuresis in individuals with impaired renal function Apr 23, 2004 Aug 25, 2009 Patent